Versican modulates embryonic chondrocyte morphology via the epidermal growth factor-like motifs in G3

被引:36
|
作者
Zhang, Y
Wu, YJ
Cao, L
Lee, V
Chen, LW
Lin, ZS
Kiani, C
Adams, ME
Yang, BB
机构
[1] Sunnybrook & Womens Coll Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada
[2] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
基金
英国医学研究理事会;
关键词
proteoglycan; G3; domain; CRD; CBP; actin;
D O I
10.1006/excr.2000.5095
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This investigation was designed to characterize the effect of the extracellular matrix molecule versican on chondrocyte morphology, using the well-studied chondrocyte cell culture system. When cultured chondrocytes reverted or "dedifferentiated" to a fibroblastlike morphology, we found that versican expression was significantly enhanced. Transfection of chondrocytes, isolated from embryonic chicken sterna, with a chicken miniversican construct accelerated the reversion process, while expression of an antisense construct inhibited it. A mutant miniversican lacking two epidermal growth factor-like motifs (versican Delta EGF) promoted differentiation, as shown by morphological changes and changes in the expression of other extracellular matrix molecules. A truncated versican mutant, the G3 Delta EGF, a G3 domain lacking its two epidermal growth factor-like motifs, also enhanced differentiation. This effect is related to G3 Delta EGF-induced change in cytoskeleton, since transfected cells exhibited misassembly of actin filaments. This article thus provides the first evidence that versican modulates chondrocyte morphology via changes in cytoskeletal structure, and may imply that extracellular matrix molecules play an important role in cell differentiation. (C) 2001 Academic Press.
引用
收藏
页码:33 / 42
页数:10
相关论文
共 50 条
  • [1] The G3 domain of versican enhances cell proliferation via epidermal growth factor-like motifs
    Zhang, Y
    Cao, L
    Yang, BL
    Yang, BB
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (33) : 21342 - 21351
  • [2] G3 domain of versican enhances cell proliferation via epidermial growth factor-like motifs
    Zhang, Yaou
    Cao, Liu
    Yang, Bing L.
    Yang, Burton B.
    Journal of Biological Chemistry, 1998, 273 (33):
  • [3] The g3 domain of versican inhibits mesenchymal chondrogenesis via the epidermal growth factor like motifs
    Zhang, Y
    Cao, L
    Kiani, CG
    Yang, BL
    Yang, BB
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (49) : 33054 - 33063
  • [4] Versican G3 domain regulates neurite growth and synaptic transmission of hippocampal neurons by activation of epidermal growth factor receptor
    Xiang, Yun-Yan
    Dong, Haiheng
    Wan, Yudi
    Li, Jingxin
    Yee, Albert
    Yang, Burton B.
    Lu, Wei-Yang
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (28) : 19358 - 19368
  • [5] Direct and inverted epidermal growth factor-like motifs in proteins associated with development and tumor growth.
    Terentiev, Alexander
    Moldogazieva, N. T.
    Mokhosoev, I. M.
    TUMOR BIOLOGY, 2006, 27
  • [6] Nephronectin promotes osteoblast differentiation via the epidermal growth factor-like repeats
    Kahai, Shireen
    Lee, Shao-Chen
    Seth, Arun
    Yang, Burton B.
    FEBS LETTERS, 2010, 584 (01): : 233 - 238
  • [7] Hematopoietic activity of a stromal cell transmembrane protein containing epidermal growth factor-like repeat motifs
    Moore, KA
    Pytowski, B
    Witte, L
    Hicklin, D
    Lemischka, IR
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (08) : 4011 - 4016
  • [8] Heparin Binding Epidermal Growth Factor-Like Growth Factor and PD169316 Prevent Apoptosis in Mouse Embryonic Stem Cells
    Krishnamoorthy, Malini
    Heimburg-Molinaro, Jamie
    Bargo, Ana M.
    Nash, Rachel J.
    Nash, Rodney J.
    JOURNAL OF BIOCHEMISTRY, 2009, 145 (02): : 177 - 184
  • [10] Novel gene containing multiple epidermal growth factor-like motifs transiently expressed in the papillae of the ascidian tadpole larvae
    Arnold, JM
    Eri, R
    Degnan, BM
    Lavin, MF
    DEVELOPMENTAL DYNAMICS, 1997, 210 (03) : 264 - 273